Optellum’s Post

🌟 Exciting News in Cancer Care! 🌟 A groundbreaking development, the Liberty device, has just received regulatory approval and is set to revolutionise the treatment experience for cancer patients. This innovative technology allows patients to conduct blood tests at home and directly upload the results, significantly reducing the need for frequent, exhausting hospital visits. Why This Is a Game Changer: 1) Increased Patient Autonomy: Patients can manage their health more independently, reducing stress and anxiety associated with regular hospital visits—especially for those with a fear of needles. 2) Enhanced Clinic Efficiency: Healthcare providers can now assess a patient’s readiness for chemotherapy cycles remotely. This not only saves time but also ensures that resources are allocated more efficiently, reducing the occurrence of wasted chemotherapy preparations. 3) Improved Quality of Life: By minimising the physical and mental exhaustion of hospital trips, patients can maintain a more comfortable daily routine and focus on recovery and well-being. 4) Potential for Broader Application: When used in conjunction with other at-home monitoring tools, Liberty can provide comprehensive insights into a patient’s health, further enhancing the ability to tailor treatment plans effectively. Though currently piloted in a limited scope, the potential of this device to boost productivity and patient care is immense. Liberty could lead to significant advancements in how blood testing and health monitoring are conducted for cancer patients. Stay tuned for more updates as this technology progresses through further trials and begins to impact lives more broadly. The future of patient-centric cancer treatment is here! #HealthTech #CancerCare #Innovation #PatientCare #NHS https://lnkd.in/gaE6HgGU

This study gives a beacon of hope for incredibly early detection of lung cancer!!!💯 You might have heard AI detecting cancer early, imagine detecting lung cancer 3 years, before symptoms appear !!! Isn't that exciting?!!! Here's a ground breaking breakthrough💥 🔬 A recent study conducted at Phrapokklao Hospital’s Cancer Centre in Bangkok used an AI-powered chest X-ray software developed by Mumbai-based Qure.ai, which detected precancerous lung nodules long before they would’ve been caught by traditional methods. 📃The study was presented at the World Conference on Lung Cancer in San Diego, which looked at X-ray scans of newly diagnosed lung cancer patients in whom previous scans (taken during health checkups at least six months prior) had missed reporting the nodules. Around 80% of lung cancers are missed on chest X-rays, but AI-assisted X-ray scans could be more effective, said the researchers. 🫁 And this breakthrough is important for lung cancer or any other cancer because cancer often does not show symptoms until it has progressed to an advanced stage, making it more challenging to treat effectively. By the time a patient experiences symptoms , specifically for lung cancer , like persistent cough, chest pain, or difficulty breathing, the cancer may have already spread, limiting treatment options. On the other hand, treatment methods including surgery, radiation, and chemotherapy may be more successful if lung cancer is found early by screening. Research indicates that individuals with lung cancer who receive an early diagnosis have a significantly better survival than those who receive a later diagnosis. Just like AI is lending helping hand in every sector, so is it doing in health care 🩺💊 !! #LungCancer #AI #WorldConference #Qure.ai

We need to change the narratives - One we need to TALK abut CANCER and Two we need to TALK about DEATH. Death is the natural progression of live. Cancer can be prevented and in many cases the treatment outcomes can be impacted hugely with early detection and screening at primary health care level and timely referral to treatment services. Emotional support of part of the cancer journey. The value of support services as part of palliative care should be emphasised. AND the fact that palliative care is NOT end-of-life care. It starts with the actual cancer diagnosis. How many cancer patients are allowed the luxury of disease planning discussions with their MDT. Are clinical health care professionals equipped to have these discussions with their patients? Many questions that we have to answer in the #54DaysofCancerAdvocacy Thank you Miriam Mutebi, MD,MSc,FACS - Excellent series to open the discussions we need to have. Cancer Alliance (South Africa) Linda Greeff Icon Oncology South Africa Dr Busisiwe Ndlovu CANSA The Cancer Association of South Africa

Less than three months into their partnership with Providertech, CHRISTUS Health began to see significantly higher response rates than the national average for lung cancer screenings. Read on to learn more about this project and how you can start using conversational AI to scale a population outreach project and reach more patients for timely cancer screenings: https://lnkd.in/gSm9E2rs #providertech #casestudy #conversationalai #healthoutcomes #healthit #digitalhealthcare #healthai

Health Ministry is considering integrating AI to enhance disease detection, particularly for cancer, in public hospitals, pending validation of its safety, efficacy, and cost-effectiveness. AI has shown promise in improving diagnostic accuracy and early detection, with ongoing evaluations by MaHTAS for lung, breast, and cervical cancers. Initial studies indicate AI’s effectiveness in assisting radiologists, especially in lung cancer detection, by improving sensitivity and reducing false positives. While AI shows potential in breast and cervical cancer screening, more robust evidence is needed before widespread adoption. Trials are underway at key hospitals to assess broader implementation. Read more: https://ow.ly/hvOb50Ubtrz

When dealing with cancer, a common and dangerous myth is that hospitals are places where you go to die:(. Cancer fatalism—the belief that cancer is incurable—often leads to the misconception that hospitals are only for the end stages of the disease. This mindset can discourage people from seeking medical care and lead them to rely on unproven remedies, allowing the disease to advance unchecked. To combat this, we need to harness the power of cancer advocates and survivors. Their stories of recovery and hope can help change perceptions and encourage more proactive approaches to treatment. Another prevalent myth is that biopsies cause cancer to spread, leading some to skip this crucial step and opt for surgery instead. This approach is flawed and risky. A thorough triple diagnostic process, that includes a comprehensive medical exam by the physician, appropriate imaging of the area/ region affected, and often a core needle biopsy to confirm the diagnosis, is essential for accurate diagnosis and effective treatment planning. Skipping these steps can lead to unnecessary surgeries and additional emotional, psychological, and financial burdens. In oncology, the treatment approach is determined by the tumor's biology and stage. Accurate diagnosis and a tailored, multidisciplinary strategy are crucial for effective treatment. The reality is that surgery can be unforgiving, and you want to get it right the first time. For instance, the surgery done for benign lumps is very different from a cancer surgery and is equally different for an indeterminate lump.  Surgery should therefore never be a matter of guesswork or hazardous experimenting, but about making precise, informed, evidence-based decisions. Thus, we must work with communities to dispel the stigma surrounding hospital visits and emphasize the importance of thorough assessments. Early detection and proper diagnosis are key to saving lives—let's ensure we get it right the first time. Read more👉 https://lnkd.in/dqk2cSDi. #AfricaCancerDialogues #54DaysofCancerAdvocacy #Day9 Union for International Cancer Control (UICC) American Society of Clinical Oncology (ASCO) World Health Organization African Region OncoDaily

March is #colorectalcancerawareness month. So, it's a good time to ask, "Can a blood test 💉 efficiently flag for colorectal cancer risk?" Answer: Yes, either with a) an 💰expensive💰 new test, or b) with an inexpensive CBC paired with a proven #ai solution. I wrote about how clinical AI can supercharge cancer screening to save lives and reduce #healthcare costs, and how Geisinger has proven the results. https://hubs.ly/Q02g9c4L0 cc: Medial EarlySign

130,000 U.S. cancer cases went undiagnosed in Covid pandemic, study finds as reported in this article by STAT. If more tests like Cologuard in which samples may be collected at home were available for cancer detection, would the number of missed diagnoses have been lower? Do data for colon cancer diagnoses in the U.S. in 2020 suggest a lower deficit of diagnoses? Future disruptions to the U.S. healthcare system may benefit from greater utilization of #liquidbiopsy. https://lnkd.in/gpbFithT.